PHARMA COMPANY IN NEXUS WITH DOCTORS CAUSING DEATH OF MY WIFE. THIS WAS SUPPORTED BY FDA.
2. Cancer drug Rokfos was administered as a trial to cure stiff neck in a single day at Maruti Nursing Home, Mumbai.
3. The drug caused serious adverse drug reactions (ADRs) never seen before with zoledronic acid, the ingredient of the injection.
4. This injection has to be administered only once in a year even for bone cancer patients. It was administered without the patient's or relatives' consent. Maruti Nursing Home doctors watched the patient sinking to her death for five days and sent her to Platinum Hospitals with no details in Discharge Card.
5. Platinum Hospitals also colluded with Maruti Nursing Home and hushed up the serious ADRs. Nothing of ADRs in in-patient records or Discharge Card.
6. Jupiter Hospital where my wife finally succumbed to her death gave a false Death Certificate and hushed up the serious ADRs in in-patient records.
7. Drug manufacturer Cipla Limited hushed up the ADRs in spite of repeated appeals by me to investigate the said drug in the interest of medical science to save lives in the future.
8. FDA Maharashtra Mumbai fully colluded with Cipla Limited as well as the doctors and hospitals.
9. FDA Maharashtra Commissioner, Dr.Pallavi Darade suppressed Order for immediate action by PMOPG cell dated 06/12/2018.
10. CDSCO is making the aggrieved party run from Pillar to Post since 1 1/2 years in spite of full evidence of FOUL PLAY and in spite of Order from Consumer Court holding the doctors and hospitals "Guilty" of causing death of my wife from drug Rokfos.
11. Cipla was informed of the ADRs by the treating doctor and myself in August 2014.
12. Cipla did not follow statutory guidelines. Did not investigate, did not recall the drugs (mandatorily required as per Schedule 'M' of Drugs and Cosmetics Rules) and did not report to FDA, DCGI and PVPI.
13. Cipla took the aggrieved consumer for a ride for four long years.
14. Finally law caught up with Cipla and a show cause was sent to Cipla Goa by FDA Goa (the drug was manufactured at Goa). Cipla Goa informed that all product complaints were handled at Cipla Drugs Safety, Mumbai and not at Goa.
15. However, Cipla Global Head Pharmacovigilance gave his explanation to FDA Goa Director who sent a copy of the same to me.
16. On finding the totally false and fictitious explanation from Cipla which included false, defamatory, derogatory and disgusting remarks on my wife's health condition, i have asked for an unconditional apology from Cipla Board and Management.
17. The physician who had certified my wife as "fit for surgery" for cord compression (cause of stiff neck) had noted in in-patient record that my wife was "pre-morbidly healthy" "No major illness in the past" "No addictions" "No known allergies"
18. Cipla pharmacovigilance portrayed my wife as "PARALYTIC" having spinal tuberculosis, bone tuberculosis and arthralgia.
19. Further stated that "On an unknown date she was administered an unknown steroid for bone tuberculosis. That this unknown steroid could be the cause of Aplastic Anaemia or bone marrow failure.
20. Cipla created an imaginary THESIS - Aplastic Anaemia vs Anti-tubercular therapy and deceived FDA Goa Director that their drug Rokfos was not the cause of death.
21. After four long years Cipla told me that they had investigated their drug and reported to FDA Goa, DCGI and PVPI. Cipla was not aware that i had already asked the three concerned authorities who had confirmed to me that Cipla had not reported the ADRs to them.
22. Finally, Cipla after getting cornered had told me that they will comply with the directions of the concerned authorities.
23. CDSCO/FDA Mumbai/FDA Goa/Mumbai Police are not acting since five years.
24. This made me address the issue jointly with the President, PM and CJI on 17th December 2019.
25. Supreme Court has registered my grievance.
26.PM has warned pharma companies.
27. PM is aware of the full story. Why don't CDSCO/FDA/Mumbai Police take action against Cipla, doctors and hospitals in my criminal complaints ?
26. This shows the Power and might of the Pharma Industry over the Government.
27. Can Local Circles take this matter further to the PM ?
Thanking you for your co-operation,
Umeshchandra Barkur more
"Cartel of Doctors, Pharma, Diagnostic Labs fleecing patients: Madras HC take suo motu cognizance"
The Madras High Court on Monday took suo motu cognisance of unethical practices in the medical industry. As recorded in the order passed by the Bench of Justices N Kirubakaran and P Velmurugan,
“… it is complained that drugs are overpriced and unnecessary drugs are being prescribed by a section of medical practitioners at the instance of pharmaceutical companies, apart from prescribing unnecessary tests, scans, X – Rays etc., for commission from diagnostic laboratories. It is being said that Medical Mafia is controlling the pharmaceutical field and they are responsible for overpricing of the drugs.”
The case prompting the observation was a an appeal by the Income Tax department against an order of the Income Tax Appellate Tribunal (ITAT), which had ruled in favour of a Pharma company, Fourrts (India) Labs Pvt. Ltd.
The tax dispute emerged after income returns submitted by Fourrts for the assessment year 2012-2013 came under scrutiny. The company had claimed a deduction of Rs 5,45,77,209 as Licences & Taxes and Rs 42,81,986 towards “Sales and Promotion Expenses” including payments to doctors for the promotion of the Company’s brands of medicine.
It was also noted that in the previous year, the National Pharmaceutical Pricing Authority [NPPA] had ordered Fourrts to refund the excess amount collected by overcharging drugs higher than those fixed or notified by the Government, within interest. Whereas Fourrts contended that the same could not be considered a penalty and that the same was a refund, the assessing officer disagreed on this aspect.
The assessment order was challenged by the Fourrts before the Commissioner of Income Tax (Appeals), who dismissed the appeal. The appellant, however, succeeded on second appeal before the ITAT. The High Court was approached by the Income Tax Department on further appeal.
While the Court admitted the appeal, the Bench also opined that the case raises larger issues which the Court ought to consider suo motu.
“Though the case on hand is a Tax Case Appeal filed under Section 260A of the Income Tax Act, 1961 this Court suo motu invokes Article 226 to consider the larger issues of bribing of doctors and overpricing of drugs by Pharmaceutical Companies, as they directly affect citizens violating their rights under Article 21 of Constitution of India. This Constitutional Court cannot restrict itself to the issue involved in the appeal and it is duty bound to issue remedial directions to address the above larger issues.” more